Lands' End (LE) Q1 2027 earnings summary

Executive summary

• Q1 FY26 revenue declined 8.5–9% to $238.9M–$239M due to temporary U.S. distribution center disruptions, but underlying demand and customer acquisition remained strong, especially in Europe.

• The JV with WHP Global closed April 1, 2026, exchanging 50% of brand IP for $300M, eliminating $234M in term loan debt, and transforming the business model and balance sheet.

• Net income surged to $330.7M, driven by a $491.6M gain from the WHP Transaction, while adjusted EBITDA and gross margin were pressured by new royalty payments, tariffs, and shipment delays.

• WHP Global acquired ~7% equity via a $100M tender offer at a premium, providing immediate liquidity to shareholders.

• The company is guiding for positive revenue and adjusted EBITDA growth for FY26, with a strong balance sheet and $100M share repurchase authorization.

Financial highlights

• Q1 revenue: $238.9M–$239M, down 8.5–9% year-over-year, mainly due to warehouse disruptions.

• Adjusted EBITDA: $(6.2)M to -$6M, down from prior year, reflecting shipment timing, new royalty structure, and tariff pressure.

• Adjusted net loss: $3.5M ($0.11/share) vs. adjusted net income of $5M ($0.18/share) last year.

• Inventory: $299.9M–$300M at quarter-end, up from $262M, due to timing and tariff impacts.

• Debt: $30M ABL borrowings, down from $40M; term loan fully repaid using $300M JV proceeds.

Outlook and guidance

• Q2 net revenue expected at $290M–$310M; adjusted net income $2M–$5M; adjusted EPS $0.06–$0.16; adjusted EBITDA $11M–$14M.

• FY26 net revenue guidance: $1.3B–$1.4B; adjusted net income $10M–$20M; adjusted EPS $0.32–$0.65; adjusted EBITDA $68M–$78M.

• Three-year targets: mid-single-digit annual revenue growth, high single-digit adjusted EBITDA margin, supported by core business and JV profit streams.

• CapEx for FY26: ~$40M, mainly for SAP/technology implementation; maintenance CapEx expected to drop to $20M or less post-SAP.

• Management expects cash on hand, operations, and ABL Facility to be sufficient for at least the next 12 months.